Abstract
Definition of the T-lymphocyte responses to dengue viruses should aid in the development of safe and effective vaccines and help to explain the pathophysiology of dengue hemorrhagic fever and dengue shock syndrome. In this study, we demonstrated that dengue virus-specific T lymphocytes were detected in spleen cells from dengue virus-immune mice using an in vitro proliferation assay. Following immunization with a single dose of infectious dengue virus, murine lymphocytes showed increased proliferation when incubated in the presence of viral antigens of the same serotype but not in the presence of control antigens. Depletion experiments with antibody and complement showed that the population of responding cells expressed the Thy1+ L3T4+ Lyt2- phenotype. This indicates that the predominant proliferating cells are T lymphocytes of the helper-inducer phenotype. Dengue virus-specific memory lymphocyte responses were detectable for at least 22 weeks after immunization. The response to primary infection was primarily serotype specific, with some serotype cross-reactivity present at a low level. We demonstrated that lymphocytes from mice immunized with dengue 4 virus proliferate in response to a combination of dengue 4 virus C, pre-M, E, NS1, and NS2a proteins expressed in Sf9 cells with a recombinant baculovirus, and, to a lesser extent, to the dengue 4 virus E protein alone.
MeSH Terms
Animals
Antigens, Viral/immunology
Dengue Virus/immunology
Lymphocyte Activation
Male
Mice
Mice, Inbred BALB C
Phenotype
Recombinant Proteins/immunology
Species Specificity
T-Lymphocytes/immunology
Vero Cells
Viral Proteins/immunology
Chemicals
Antigens, Viral
Recombinant Proteins
Viral Proteins
Authors & Affiliations
5 authors, click to expand affiliations / ORCID
Rothman A L
Department of Medicine, University of Massachusetts Medical Center, Worcester 01655.
Kurane I
Zhang Y M
Lai C J
Ennis F A
References (23)
23 references, click to expand
-
A prospective study of dengue infections in Bangkok.
Am J Trop Med Hyg. 1988 Jan;38(1):172-80
PMID: 3341519
-
Pathogenesis of dengue: challenges to molecular biology.
Science. 1988 Jan 29;239(4839):476-81
PMID: 3277268
-
Immunization of mice with dengue structural proteins and nonstructural protein NS1 expressed by baculovirus recombinant induces resistance to dengue virus encephalitis.
J Virol. 1988 Aug;62(8):3027-31
PMID: 2969058
-
Dengue 2 virus envelope protein expressed by a recombinant vaccinia virus fails to protect monkeys against dengue.
J Gen Virol. 1988 Aug;69 ( Pt 8):1921-9
PMID: 3404119
-
Gamma interferon augments Fc gamma receptor-mediated dengue virus infection of human monocytic cells.
J Virol. 1988 Nov;62(11):3928-33
PMID: 2459406
-
Human T cell responses to dengue virus antigens. Proliferative responses and interferon gamma production.
J Clin Invest. 1989 Feb;83(2):506-13
PMID: 2521489
-
Observations related to pathogenesis of dengue hemorrhagic fever. IV. Relation of disease severity to antibody response and virus recovered.
Yale J Biol Med. 1970 Apr;42(5):311-28
PMID: 5419206
-
Dengue viruses and mononuclear phagocytes. I. Infection enhancement by non-neutralizing antibody.
J Exp Med. 1977 Jul 1;146(1):201-17
PMID: 406347
-
Dengue haemorrhagic fever--a public health problem and a field for research.
Bull World Health Organ. 1980;58(1):1-21
PMID: 6966540
-
Induction and characterization of delayed-type hypersensitivity to dengue virus in mice.
J Infect Dis. 1982 Aug;146(2):235-42
PMID: 7108274
-
Lyt phenotype and H-2 compatibility requirements of effector cells in the delayed-type hypersensitivity response to dengue virus infection.
Infect Immun. 1984 Jan;43(1):429-31
PMID: 6690413
-
Lysis of dengue virus-infected cells by natural cell-mediated cytotoxicity and antibody-dependent cell-mediated cytotoxicity.
J Virol. 1984 Oct;52(1):223-30
PMID: 6207308
-
Risk factors in dengue shock syndrome: a prospective epidemiologic study in Rayong, Thailand. I. The 1980 outbreak.
Am J Epidemiol. 1984 Nov;120(5):653-69
PMID: 6496446
-
Epitopic analysis of antigenic determinants on the surface of dengue-2 virions using monoclonal antibodies.
Am J Trop Med Hyg. 1985 Jan;34(1):162-9
PMID: 2578750
-
Lethal 17D yellow fever encephalitis in mice. I. Passive protection by monoclonal antibodies to the envelope proteins of 17D yellow fever and dengue 2 viruses.
J Gen Virol. 1986 Feb;67 ( Pt 2):229-34
PMID: 3944585
-
Differences in antigen presentation to MHC class I-and class II-restricted influenza virus-specific cytolytic T lymphocyte clones.
J Exp Med. 1986 Apr 1;163(4):903-21
PMID: 3485173
-
Protection of mice against dengue 2 virus encephalitis by immunization with the dengue 2 virus non-structural glycoprotein NS1.
J Gen Virol. 1987 Mar;68 ( Pt 3):853-7
PMID: 3819700
-
Monoclonal antibodies against dengue 2 virus E-glycoprotein protect mice against lethal dengue infection.
Am J Trop Med Hyg. 1987 Mar;36(2):427-34
PMID: 3826503
-
Improvement of the in vitro T cell proliferation assay by a modified method that separates the antigen recognition and IL-2-dependent steps.
J Immunol Methods. 1987 May 20;99(2):221-8
PMID: 3108408
-
Disease severity-related antigenic differences in dengue 2 strains detected by dengue 4 monoclonal antibodies.
J Med Virol. 1987 Jun;22(2):169-74
PMID: 2440987
-
The nucleotide sequence of dengue type 4 virus: analysis of genes coding for nonstructural proteins.
Virology. 1987 Aug;159(2):217-28
PMID: 3039728
-
Flavivirus-specific murine L3T4+ T cell clones: induction, characterization and cross-reactivity.
J Gen Virol. 1987 Oct;68 ( Pt 10):2655-63
PMID: 2822843
-
From the World Health Organization. Current approaches to the development of dengue vaccines and related aspects of the molecular biology of flaviviruses.
J Infect Dis. 1988 May;157(5):1105-11
PMID: 2452218